These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37276796)

  • 21. Guest-Host Supramolecular Assembly of Injectable Hydrogel Nanofibers for Cell Encapsulation.
    Miller B; Hansrisuk A; Highley CB; Caliari SR
    ACS Biomater Sci Eng; 2021 Sep; 7(9):4164-4174. PubMed ID: 33891397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
    Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S
    J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-Interpenetrating Polymer Network of Hyaluronan and Chitosan Self-Healing Hydrogels for Central Nervous System Repair.
    Liu Y; Hsu YH; Huang AP; Hsu SH
    ACS Appl Mater Interfaces; 2020 Sep; 12(36):40108-40120. PubMed ID: 32808527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.
    Shi G; Kong J; Wang Y; Xuan Z; Xu F
    J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient Mild Photothermia Improves Therapeutic Performance of Oral Nanomedicines with Enhanced Accumulation in the Colitis Mucosa.
    Ma Y; Gou S; Zhu Z; Sun J; Shahbazi MA; Si T; Xu C; Ru J; Shi X; Reis RL; Kundu SC; Ke B; Nie G; Xiao B
    Adv Mater; 2024 Apr; 36(14):e2309516. PubMed ID: 38085512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bio-adhesive and ROS-scavenging hydrogel microspheres for targeted ulcerative colitis therapy.
    Sun Q; Chen J; Zhao Q; He Z; Tang L; Pu Y; He B
    Int J Pharm; 2023 May; 639():122962. PubMed ID: 37068716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injectable thermo-sensitive and wide-crack self-healing hydrogel loaded with antibacterial anti-inflammatory dipotassium glycyrrhizate for full-thickness skin wound repair.
    Zhu DY; Chen ZP; Hong ZP; Zhang L; Liang X; Li Y; Duan X; Luo H; Peng J; Guo J
    Acta Biomater; 2022 Apr; 143():203-215. PubMed ID: 35245682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis.
    Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C
    J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversibly Assembled Electroconductive Hydrogel via a Host-Guest Interaction for 3D Cell Culture.
    Xu Y; Cui M; Patsis PA; Günther M; Yang X; Eckert K; Zhang Y
    ACS Appl Mater Interfaces; 2019 Feb; 11(8):7715-7724. PubMed ID: 30714715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
    Ren TH; Lv MM; An XM; Leung WK; Seto WK
    J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angelica oil restores the intestinal barrier function by suppressing S100A8/A9 signalling in mice with ulcerative colitis.
    Liu C; He YX; Zhang JN; Yang F; Wang SY; Hu JL; Yu Y
    Phytomedicine; 2023 Jan; 108():154490. PubMed ID: 36332386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of Lizhong decoction on ulcerative colitis in mice by suppressing inflammation and ameliorating gut barrier.
    Shen Y; Zou J; Chen M; Zhang Z; Liu C; Jiang S; Qian D; Duan JA
    J Ethnopharmacol; 2020 Sep; 259():112919. PubMed ID: 32360800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
    Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
    Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy.
    Zeng Y; Zhang C; Du D; Li Y; Sun L; Han Y; He X; Dai J; Shi L
    Acta Biomater; 2022 Jun; 145():43-51. PubMed ID: 35398545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
    Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
    Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of Bioglass Improved the Mechanical Stability and Bioactivity of Alginate/Carboxymethyl Chitosan Hydrogel Wound Dressing.
    Wu X; Li H
    ACS Appl Bio Mater; 2021 Feb; 4(2):1677-1692. PubMed ID: 35014515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo.
    Prakash AN; Prasad N; Puppala ER; Panda SR; Jain S; Ravichandiran V; Singh M; Naidu VGM
    Int Immunopharmacol; 2023 Sep; 122():110585. PubMed ID: 37421777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4/MyD88/NF-κB signaling in an experimental model of ulcerative colitis.
    Ye X; Xu H; Xu Y
    Folia Histochem Cytobiol; 2022; 60(4):311-322. PubMed ID: 36504132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis.
    Schmitt H; Ulmschneider J; Billmeier U; Vieth M; Scarozza P; Sonnewald S; Reid S; Atreya I; Rath T; Zundler S; Langheinrich M; Schüttler J; Hartmann A; Winkler T; Admyre C; Knittel T; Dieterich Johansson C; Zargari A; Neurath MF; Atreya R
    J Crohns Colitis; 2020 May; 14(4):508-524. PubMed ID: 31630153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.